Cilostazol protects against degenerative cervical myelopathy injury and cell pyroptosis via TXNIP-NLRP3 pathway
Crossref DOI link: https://doi.org/10.1186/s13008-024-00108-y
Published Online: 2024-01-17
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Xu, Fei
Tian, Zhuo
Wang, Zhengguang
Text and Data Mining valid from 2024-01-17
Version of Record valid from 2024-01-17
Article History
Received: 19 November 2023
Accepted: 11 January 2024
First Online: 17 January 2024
Declarations
:
: The authors declare no competing interests.